BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 11681003)

  • 1. [Survival benefits of and indications for extended surgery for advanced gastric cancer].
    Aikou T; Natsugoe S; Hokita S
    Nihon Geka Gakkai Zasshi; 2001 Oct; 102(10):764-9. PubMed ID: 11681003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indications for pancreaticosplenectomy in advanced gastric cancer.
    Chikara K; Hiroshi S; Masato N; Hirotoshi A; Goro M; Hidetaka O
    Hepatogastroenterology; 2001; 48(39):908-12. PubMed ID: 11462954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Disciplinarian of lymph node metastasis and effect of paraaortic lymph nodes dissection on clinical outcomes in advanced gastric carcinoma].
    Zhan WH; Han FH; He YL; Li YM; Zheng ZQ; Peng JS; Cai SR; Ma JP
    Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Jan; 9(1):17-22. PubMed ID: 16437364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indications for paraaortic lymph node dissection in gastric cancer patients with paraaortic lymph node involvement.
    Kunisaki C; Shimada H; Yamaoka H; Takahashi M; Ookubo K; Akiyama H; Nomura M; Moriwaki Y
    Hepatogastroenterology; 2000; 47(32):586-9. PubMed ID: 10791244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of paraaortic lymph node dissection for advanced gastric cancer.
    Isozaki H; Okajima K; Fujii K; Nomura E; Izumi N; Mabuchi H; Nakamura M; Hara H
    Hepatogastroenterology; 1999; 46(25):549-54. PubMed ID: 10228860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Extended gastric surgery: is paraaortic lymph node dissection essential for advanced gastric cancer?].
    Aikou T; Natsugoe S; Hokita S
    Gan To Kagaku Ryoho; 1998 Mar; 25(4):498-503. PubMed ID: 9530355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paraaortic lymphadenectomy in patients with advanced carcinoma of the upper-third of the stomach.
    Baba M; Hokita S; Natsugoe S; Miyazono T; Shimada M; Nakano S; Takao S; Aikou T
    Hepatogastroenterology; 2000; 47(33):893-6. PubMed ID: 10919056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paraaortic lymph node dissection for gastric cancer in 244 consecutive cases.
    Kosaka T; Usami K; Ueshige N; Hasegawa T; Yoshitani S; Sugaya J; Nakano Y; Takashima S
    Hepatogastroenterology; 2006; 53(70):629-33. PubMed ID: 16995477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of extended lymph node dissection for gastric cancer cases with N2 lymph node metastasis.
    Seto Y; Nagawa H; Muto T
    Int Surg; 1997; 82(3):257-61. PubMed ID: 9372370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence of survival benefit of extended (D2) lymphadenectomy in western patients with gastric cancer based on a new concept: a prospective long-term follow-up study.
    Roukos DH; Lorenz M; Encke A
    Surgery; 1998 May; 123(5):573-8. PubMed ID: 9591011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current status and future perspectives in gastric cancer management.
    Roukos DH
    Cancer Treat Rev; 2000 Aug; 26(4):243-55. PubMed ID: 10913380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metastasis in para-aortic lymph nodes in patients with advanced gastric cancer, treated with extended lymphadenectomy.
    Yonemura Y; Wu CC; Fukushima N; Honda I; Bandou E; Kawamura T; Kamata S; Yamamoto H; Kim BS; Matsuki N; Sawa T; Noh SH;
    Hepatogastroenterology; 2007 Mar; 54(74):634-8. PubMed ID: 17523339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resection for gastric cancer in the community.
    van de Velde CJ
    Semin Oncol; 2005 Dec; 32(6 Suppl 9):S90-3. PubMed ID: 16399441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastric carcinoma: does lymph node dissection alter survival?
    Wanebo HJ; Kennedy BJ; Winchester DP; Fremgen A; Stewart AK
    J Am Coll Surg; 1996 Dec; 183(6):616-24. PubMed ID: 8957465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial.
    Hartgrink HH; van de Velde CJ; Putter H; Bonenkamp JJ; Klein Kranenbarg E; Songun I; Welvaart K; van Krieken JH; Meijer S; Plukker JT; van Elk PJ; Obertop H; Gouma DJ; van Lanschot JJ; Taat CW; de Graaf PW; von Meyenfeldt MF; Tilanus H; Sasako M
    J Clin Oncol; 2004 Jun; 22(11):2069-77. PubMed ID: 15082726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Surgical treatment and prognosis analysis for patients with gastric cancer infiltrating esophagus].
    Han FH; Zhan WH; He YL; Li YM; Zheng ZQ; Peng JS; Cai SR; Ma JP
    Zhonghua Wei Chang Wai Ke Za Zhi; 2005 May; 8(3):199-202. PubMed ID: 16167226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lymph node metastasis and the extent of lymph node dissection for gastric cancer: report of 326 cases].
    Wan Y; Pan Y; Liu Y; Wang Z; Ye J; Huang S
    Zhonghua Wai Ke Za Zhi; 2000 Oct; 38(10):752-5. PubMed ID: 11832155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Standard strategy for lymph node dissection in advanced gastric cancer patients].
    Fukagawa T
    Nihon Geka Gakkai Zasshi; 2012 Jan; 113(1):4-7. PubMed ID: 22413548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of extended lymphadenectomy on survival in patients with gastric adenocarcinoma.
    Volpe CM; Koo J; Miloro SM; Driscoll DL; Nava HR; Douglass HO
    J Am Coll Surg; 1995 Jul; 181(1):56-64. PubMed ID: 7599772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymph node dissection in surgical treatment for remnant stomach cancer.
    Kunisaki C; Shimada H; Nomura M; Hosaka N; Akiyama H; Ookubo K; Moriwaki Y; Yamaoka H
    Hepatogastroenterology; 2002; 49(44):580-4. PubMed ID: 11995502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.